Related Tags >> Ranbaxy patent FDA Pfizer

Generics News

Most Popular Generics Story

Pfizer's future rests with biotech

September 13, 2007 — 11:00am ET | By Maureen Martino

At this week’s Bear Stearns Healthcare Conference, Pfizer discussed its plans for the future with analysts. As we all know, Pfizer is facing a major loss of sales when its best-selling drug... Read more...

Generics Press Releases

Mylan Receives FDA Approval for Additional Strength of Generic Restoril(R)
Mylan Receives Tentative FDA Approval for Generic Version of Singulair
Pfizer Expands Its Generics Portfolio Through Innovative Licensing Deals, Increasing Access To Medicines For Billions Worldwide
Impax Receives FDA Approval for Generic Precose Tablets, 25 mg, 50 mg and 100 mg im
Mail service and higher generic use helps keep spending in check, countering brand drug price inflation and specialty medication

Latest Headlines

Big studies don't always change doctors' habits
December 1, 2008
Report: Pfizer makes counter-offer for Ranbaxy
June 13, 2008
Daiichi Sankyo acquires Ranbaxy in $4.6B deal
June 11, 2008
ALSO NOTED: GSK releases new Cervarix data; FDA mulls DTC ads; and much more...
May 16, 2008
Pfizer gets new cancer team to advance key drugs
May 15, 2008
Spectrum sells off generic drugs
May 9, 2008
ALSO NOTED: Analysts predict trouble for second-gen Rituxan; Sucampo earns $50M on FDA approval;and much more...
April 30, 2008
Biotech's next big opportunity: Follow-ons?
April 24, 2008
ALSO NOTED: US Oncology's CFO retires; Profits rise at Novartis, Merck, Lilly; and much more...
April 21, 2008
ALSO NOTED: Meda buys late-stage drugs;Debiopharm licenses peptide;and much more...
April 14, 2008
Can Big Pharma effectively develop new drugs?
April 4, 2008
Novartis discovery chief departs in management shakeup
March 20, 2008
Pfizer seeks salvation in late-stage biotherapeutics
March 5, 2008
ALSO NOTED: Harvard launches fund for biomedical tech; Neurogen outlines R&D plans; and much more...
February 8, 2008
The 2008 Election: What does it mean for drugmakers?
February 6, 2008
Budget has mandate for biogeneric approvals
February 5, 2008
Teva snaps up CoGenesys in $400M buyout
January 22, 2008
Novartis CEO: Galvus' future is uncertain
January 17, 2008
European pipeline likely to stay thin to 2009
January 14, 2008
Idera shares surge on Merck KGaA pact
December 19, 2007

Paid Research Reports

More Research Reports >>